We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Medical Devices » Research and Development

Research and Development
Research and Development RSS Feed RSS

Cardiologs’ AI Diagnostics Outperforms ECG Features in Study to Predict AFib

June 22, 2022
A new study evaluating Cardiologs’ deep learning tool for identifying patients at risk for atrial fibrillation (AFib) showed that it outperformed regular 12-lead electrocardiogram (ECG) testing. Read More

DermaSensor Reports Positive Results from Trials of its Skin Cancer Detection Device

June 17, 2022
Miami, Fla.-based DermaSensor said two studies of its handheld skin cancer detection device — which could become the first FDA-cleared device of its kind for use by primary care physicians — have demonstrated the device’s efficacy. Read More

FDA Updates Its Recognized Consensus Standards Database

June 15, 2022
The FDA has just published the agency’s latest update to its Recognized Consensus Standard Database that device sponsors can cite in their device submissions. Read More

Injectable Hydrogel for Spinal Discs Found Safe in Study, Improved Back Pain

June 15, 2022
An early feasibility study is finding that hydrogel injected into lumbar spinal discs is safe while substantially relieving chronic low back pain caused by degenerative disc disease (DDD). Read More

Clare Medical’s AI Tool Reduces ER Visits, Hospitalization by 77 Percent

June 13, 2022
Clare Medical of New Jersey reported in a recent study that its proprietary artificial intelligence (AI) tool that identifies elderly patients with a high probability of needing an emergency room (ER) visit or hospitalization within 30 days reduced these visits by 77 percent. Read More

Insulet Omnipod 5 Insulin Delivery System Shows Extended Positive Data from Trial

June 8, 2022
Insulet has released pivotal trial extension data showing that its Omnipod 5 automated insulin delivery system continued to improve glycemic outcomes in young children over 12 months of use. Read More

DarioHealth Digital Therapeutics Improves Glucose Control in Trials

June 8, 2022
New York-based DarioHealth reported positive results from several clinical trials of its digital therapeutics at the American Diabetes Association’s (ADA) 82nd Scientific Sessions in New Orleans, June 3-7. Read More

3D-Bioprinted Tissue Implant Reconstructs Human Ear in Clinical Trial

June 6, 2022
3DBio Therapeutics, a New York-based regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute in San Antonio, Texas, have partnered to reconstruct a human ear using the company’s AuriNovo 3D-bioprinted implant. Read More

Bioresorbable Nail Succeeds in Treating Fractures in Postmarket Study

June 3, 2022
Helsinki, Finland-based Bioretec’s bioresorbable Activa IM-Nail was effective in treating pediatric forearm fractures in an ongoing postmarket study by European researchers. Read More

Orthofix Artificial Cervical Disc Shows Benefit Over Spinal Fusion in Five-Year Study

June 2, 2022
Orthofix Medical’s M6-C artificial cervical disc showed significant benefit over spinal fusion in data from a five-year clinical trial conducted under and FDA Investigational Device Exemption (IDE). Read More

AdvaMed Calls on Sponsors to Strategize with Sites on Diversity Efforts

May 31, 2022
Efforts to improve diversity in clinical research can be greatly improved when sponsors take a hard look at their current practices and protocols, work directly with sites and consider adding sites well-suited for the task, a new report from the Advanced Medical Technology Association (AdvaMed) advises. Read More

Verily Smartwatch Shows Promise for Monitoring Parkinson’s Disease

May 27, 2022
Verily Life Sciences’ investigational smartwatch has shown potential for monitoring Parkinson’s disease in home settings in a multiyear European study. Read More
Previous 1 2 3 4 5 6 7 8 9 … 61 62 Next

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared

  • FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing